These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17920718)

  • 1. Response to interferon-alpha treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B.
    Zhang Z; Zhang H; Chen D; Yao J; Fu J; Jin L; Wang FS
    J Hepatol; 2007 Dec; 47(6):751-9. PubMed ID: 17920718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical profiles of circulating dendritic cell subsets in chronically HBV-infected patients with interferon-alpha treatment].
    Yan T; Wang HF; Ji W; Zhang AM; Zhang Z; Zhang H; Wang FS
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1177-81. PubMed ID: 16029591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion.
    Shi M; Fu J; Shi F; Zhang B; Tang Z; Zhang Z; Zhang H; Jin L; Chen L; Wang H; Akbar SM; Wang FS
    Liver Int; 2009 Mar; 29(3):466-74. PubMed ID: 18710425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.
    Chen W; Zhang Z; Shi M; Chen L; Fu J; Shi F; Zhang B; Zhang H; Jin L; Wang FS
    Clin Immunol; 2008 Nov; 129(2):295-303. PubMed ID: 18774748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.
    van der Molen RG; Sprengers D; Binda RS; de Jong EC; Niesters HG; Kusters JG; Kwekkeboom J; Janssen HL
    Hepatology; 2004 Sep; 40(3):738-46. PubMed ID: 15349914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure.
    Zhang Z; Zou ZS; Fu JL; Cai L; Jin L; Liu YJ; Wang FS
    J Hepatol; 2008 Sep; 49(3):396-406. PubMed ID: 18644645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection.
    Ulsenheimer A; Gerlach JT; Jung MC; Gruener N; Wächtler M; Backmund M; Santantonio T; Schraut W; Heeg MH; Schirren CA; Zachoval R; Pape GR; Diepolder HM
    Hepatology; 2005 Mar; 41(3):643-51. PubMed ID: 15726647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of interferon-alpha therapy on the capacity of antigen presenting of peripheral blood dendritic cells from patients with chronic hepatitis B].
    Zhu CW; Wang HY; Qian F; Li M; Wu JH; Tong FY; Fei XF; Ruan CJ; Xu KL
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):14-7. PubMed ID: 14990149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency and function decrease of circulating type 2 pre-dendritic cells (pDC2) and its clinical significance in liver cirrhotic patients with chronic HBV infection].
    Duan XZ; Wang FS; Wang M; Zhuang H; Liu JC
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):274-7. PubMed ID: 15161501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of peripheral plasmacytoid dendritic cells and lymphocyte subsets in chronic hepatitis B patients treated with consensus interferon alpha].
    Zhang AM; Wang HF; Ji W; Zhang Z; Yan T; Zhang H; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):184-6. PubMed ID: 17407707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.
    Feldman S; Stein D; Amrute S; Denny T; Garcia Z; Kloser P; Sun Y; Megjugorac N; Fitzgerald-Bocarsly P
    Clin Immunol; 2001 Nov; 101(2):201-10. PubMed ID: 11683579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease.
    Wertheimer AM; Bakke A; Rosen HR
    Hepatology; 2004 Aug; 40(2):335-45. PubMed ID: 15368438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2).
    Duan XZ; Zhuang H; Wang M; Li HW; Liu JC; Wang FS
    J Gastroenterol Hepatol; 2005 Feb; 20(2):234-42. PubMed ID: 15683426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical profiles of circulating plasmacytoid dendritic cells in chronic hepatitis B patients in response to pegylated-interferon alfa-2a treatment].
    Jia N; Lin L; Guo S; Zhao G; Tang W; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):34-9. PubMed ID: 25751384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.
    Kanto T; Inoue M; Miyatake H; Sato A; Sakakibara M; Yakushijin T; Oki C; Itose I; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Infect Dis; 2004 Dec; 190(11):1919-26. PubMed ID: 15529255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of phenotype and Interferon-alpha-producing capability of circulating type II dendritic cells and its clinical implication in HBV-infected patients].
    Duan XZ; Wang FS; Wang M; Zhuang H; Liu JC; Hu JH; Li HW; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):548-52. PubMed ID: 12887741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.